Life Sciences
Case Study: Johnson & Johnson
In what The New York Times calls “one of the most complicated and gargantuan legal battles in American history,” O’Melveny is lead litigation counsel for Johnson & Johnson and subsidiary Janssen Pharmaceuticals as the companies confront thousands of claims seeking to hold them liable for the country’s opioid-abuse epidemic. Read
Entertainment & Media
AT&T and Time Warner
As lead trial counsel for both AT&T and Time Warner, O’Melveny defended the companies’ landmark US$85.4 billion merger against claims by the Department of Justice’s Antitrust Division that the transaction would harm competition and should be blocked. Read
Consumer & Retail Products
Case Study: Belk
An O’Melveny team represented the ad hoc group of Belk Inc. first lien lenders in one of the most high-profile retail restructurings of 2021, and the fastest chapter 11 case in US history. Read
Entertainment & Media
Case Study: CJ ENM
O’Melveny advised CJ ENM, the leading entertainment company originated from Korea, in a definitive agreement to acquire an 80% stake of the scripted business of US-based global premium content studio, Endeavor Content, from its parent company Endeavor Group Holdings for an enterprise valuation of US$850 million. Read
Case Study: Commonwealth of Puerto Rico
With more than US$70 billion of funded debt and approximately US$50 billion of pension obligations, Puerto Rico is facing a severe fiscal crisis. O’Melveny is representing all of the Puerto Rico governmental entities in need of financial restructuring. Read
Life Sciences
Case Study: Akeso Biopharma
O’Melveny advised Akeso Biopharma, a leading Chinese clinical-state biopharmaceutical company specializing in oncology and immunology therapies, in its listing and IPO on the Hong Kong Stock Exchange. Read
